News

Register now for free webinar on Canadian private insurance

Title: Navigating Private Insurance in Canada Date and time: November 30, 2017 from 1pm-2pm ET Register now! Canadians are often uncertain about the role and limits of their private insurance coverage. Let’s change that. For this webinar, we’re joined by Suzanne Lepage, private health plan specialist, for a discussion of Canada’s private drug plan marketplace

Read More

CCSN hosts Legislative Reception on cancer-associated thrombosis

The Canadian Cancer Survivor Network (CCSN) held their annual Legislative Reception at  Queen’s Park On October 26, 2017. The Reception was an opportunity for patients, MPPs and doctors to discuss cancer-associated thrombosis (CAT), and, despite the ongoing election-prep furor in the Ontario Legislature, the turn out to the event surpassed that of previous years. Over 30

Read More

#GivingTuesday is November 28!

It’s time to get excited for #GivingTuesday! The day is a chance for caring individuals to show their support for charities across the North America. It is the biggest single fundraising day next to New Year’s Eve, and it makes so many incredible initiatives possible.

Read More

Watch: Clinical Trials 101

This webinar will tell you what you need to know about clinical trials, their history, and help you prepare for a trial. If you’re currently considering participating in a clinical trial, we hope that this webinar helps to answer many of your questions. In the presentation you’ll learn the difference between different types of clinical

Read More

Jackie Manthorne Recognised with Jack Shapiro Lifetime Achievement Award

Ottawa, ON – Jackie Manthorne, President and CEO of the Canadian Cancer Survivor Network (CCSN), has spent over twenty years giving a voice to cancer patients, survivors and caregivers. This fall, that dedication was recognised by the Canadian Cancer Action Network (CCAN), which awarded Manthorne the 2017 Jack Shapiro Lifetime Achievement Award at their Annual

Read More

Watch: Webinar on biosimilars

Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and help to drive prices down through competition, but doctors, patients and caregivers need to understand what biosimilars are, what they can do, and

Read More